Prevymis (letermovir) - Merck (MSD)
Livtencity (maribavir) - Takeda, GSK
Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review. (PubMed, Curr Opin Infect Dis) - Oct 29, 2025 - "The most commonly identified intolerances were acute kidney injury, hematological and gastrointestinal effects in older anti-CMV agents. Fewer studies described intolerance of the newer agents. Detailed descriptions of intolerances are absent within the literature and there is an opportunity to standardize terminology used to help guide clinical practice." 
Journal • Acute Kidney Injury • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Leukopenia • Nephrology • Neutropenia • Renal Disease • Thrombocytopenia • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41151596
 
Courtney Ierano; Michelle K Yong; Nikhil Singh; Philip R Selby; Priya Garg; Violet Z Zhu
 
Oct 29, 2025
 
Prev Next